Application of adult reference intervals in children

Anne Bryde Alnor1, Pernille Just Vinholt2

  • 1Department of Clinical Biochemistry and Immunology, Lillebaelt Hospital, Kolding, Denmark. anne.alnor@rsyd.dk.

Insights

Adult reference intervals (RIs) can be applied to children as young as 2 years for some analytes. However, age- and gender-specific RIs remain necessary for many clinical laboratory tests in pediatric populations.

Area of Science:

  • Clinical Laboratory Science
  • Pediatric Medicine
  • Biochemistry

Background:

  • Establishing pediatric reference intervals (RIs) is resource-intensive and often impractical for laboratories.
  • Transference of adult RIs to pediatric populations can lead to misclassification of results.
  • Adult RIs are generally easier to establish and validate.

Purpose of the Study:

  • To assess the applicability of adult reference intervals (RIs) in pediatric populations.
  • To determine the extent to which adult RIs can be used for children aged 1 to 19 years.
  • To identify analytes requiring age- and gender-specific RIs in children.

Main Methods:

  • A local pediatric cohort (1 to <20 years) was analyzed using first-draw GP samples.
  • Excluded were samples from hospital settings or >3 GP samples per child.
  • Adult RIs were evaluated against 18-19 year olds, with data stratified by age and gender.

Main Results:

  • Adult RIs were applicable to 42% of children aged 1-9 years, 57% aged 10-14 years, and 85% aged 15-17 years.
  • Partitioning was not required for 51% of male and 69% of female pediatric strata.
  • Adult RIs are suitable for some analytes in children as young as 2 years.

Conclusions:

  • For specific analytes, partitioning between adult and pediatric RIs is unnecessary.
  • The study highlights the continued need for age- and gender-specific RIs for numerous clinical laboratory tests in children.
  • Laboratory data analysis is crucial for evaluating the necessity of partitioning reference intervals.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
215
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
214
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
200
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
155
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
145